Mike Thaman co-founded and served as a partner of Warson Capital Partners for more than 30 years. His focus at Warson included sourcing capital for growth companies as well as buy-side and sell-side M&A transactions, particularly in the areas of healthcare services, medical instruments, manufacturing, specialty retailing, and financial institutions.

During Mike’s tenure with Warson, he was introduced in 2006 to BacterioScan, Ltd. of Haifa, Israel, a start-up company with a first prototype of the instrument the Company is commercializing today. As BacterioScan Ltd. developed, Mike assisted with securing angel investors in Israel. In 2010, Warson funded proof-of-concept trials in diagnosing urinary tract infection, which produced excellent results. Upon completion of the trials, Mike formed BacterioScan, Inc., a Delaware C-corporation, and conducted a stock swap with the Israeli shareholders, resulting in the Israeli company becoming a wholly-owned subsidiary of the US corporation. Warson completed BacterioScan’s first and subsequent US capital raises, and Mike served on the board until 2015. In 2015, control of the board changed, and although the Company achieved FDA clearance in 2018, not much else was accomplished through 2021. Mike and fellow board member and Secretary/Treasurer Jim Brigham, assisted by key shareholders, began a process in 2019 that resulted in Warson regaining control of the Company in 2022, with all outstanding issues resolved in a documented settlement. Since that time, Mike has served on the board, becoming chairman in mid-2025 and taking over as CEO in October 2025.

Prior to co-founding Warson, Mike served for a four-year period as CEO of a turnaround company, which was sold, and a start-up company for which he led and completed an IPO.  Prior to that, he participated for ten years as EVP & CFO in building a $2.5 billion bank with 50 locations, leading the acquisition and expansion process and capital formation programs that raised more than $100 million to support expansion, listing the bank on the American Stock Exchange and later the New York Stock Exchange. The bank was sold in a merger of equals with another bank to form the region’s third-largest banking group at that time, now part of Regions Bank.

Mike began his career in practice as a CPA for ten years with KPMG. He has served on the boards of directors of several privately held companies and presently serves as a director of PALM Integrative Health, LLC, Chuck’s Boots, LLC, and Micron Pure, LLC. He has held leadership roles in community service organizations and the City of Frontenac, Missouri. Mike received his Bachelor of Science in Accounting from the University of Missouri.